Hansa Medical AB Revenue and Competitors
Estimated Revenue & Valuation
- Hansa Medical AB's estimated annual revenue is currently $32.1M per year.
- Hansa Medical AB's estimated revenue per employee is $155,000
Employee Data
- Hansa Medical AB has 207 Employees.
- Hansa Medical AB grew their employee count by 2% last year.
Hansa Medical AB's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | Head Supply Chain | Reveal Email/Phone |
3 | VP QA | Reveal Email/Phone |
4 | VP Regulatory Affairs | Reveal Email/Phone |
5 | VP, Head Investor Relations | Reveal Email/Phone |
6 | Head Market Access Europe | Reveal Email/Phone |
7 | Medical Science Director, R&D | Reveal Email/Phone |
8 | Senior Director CMC Operations | Reveal Email/Phone |
9 | Chief Operating Officer | Reveal Email/Phone |
10 | EU Medical Affairs Director HansaBiopharma | Reveal Email/Phone |
Hansa Medical AB Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $123.5M | 797 | 8% | N/A | N/A |
#2 | $22.2M | 143 | 7% | N/A | N/A |
#3 | $32.1M | 207 | 2% | N/A | N/A |
#4 | $10.1M | 65 | -16% | N/A | N/A |
#5 | $4.3M | 28 | -35% | N/A | N/A |
#6 | $21.4M | 138 | 20% | N/A | N/A |
#7 | $22.6M | 146 | -15% | N/A | N/A |
#8 | $11.2M | 72 | 6% | N/A | N/A |
#9 | $8.1M | 52 | -26% | N/A | N/A |
#10 | $4M | 26 | 13% | N/A | N/A |
What Is Hansa Medical AB?
Hansa Medical is a biopharmaceutical company developing novel immunomodulatory enzymes for transplantation and acute autoimmune diseases. The lead product, IdeS, is a proprietary antibody-degrading enzyme currently in late-stage clinical development for kidney transplant patients, with significant potential for further development in other solid organ transplants and in acute autoimmune indications. The company also has a strong pipeline of preclinical projects that may provide a second wave of potential drugs. Under the project name NiceR, novel immunoglobulin cleaving enzymes are developed for repeat dosing with the objective of applying the Hansa Medical technology in relapsing autoimmune diseases and oncology. Hansa Medical is based in Lund, Sweden, and its shares are listed on Nasdaq Stockholm (ticker: HMED).
keywords:N/A
N/A
Total Funding
207
Number of Employees
$32.1M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Hansa Medical AB News
... Scope And Forecast | Akari Therapeutics Plc, Annexon Inc, CuraVac Inc, Hansa Medical AB, Regenesance BV, Vitality Biopharma Inc.
Hansa Medical Ab; Regenesance Bv; Vitality Biopharma Inc Guillain Barre Syndrome Drugs Market Breakdown by Type: Coversin; Immune Globulin...
Akari Therapeutics Plc, Annexon Inc, CuraVac Inc, Hansa Medical AB, Regenesance BV, Vitality Biopharma Inc. The report provides a good overview...
Dr Pedersen is currently a Board member of Genmab A/S, Deputy Chairman of Bavarian Nordic A/S, and Board Member of Hansa Medical AB.
Other Companies in Lund
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $34.3M | 215 | N/A | N/A |
#2 | $35M | 241 | -19% | N/A |
#3 | $51.1M | 254 | 5% | N/A |
#4 | $34.1M | 258 | 6% | N/A |
#5 | $59.3M | 327 | -15% | N/A |